Loading…
Synthesis of drug-crosslinked polymer nanoparticles
A new kind of drug-crosslinked polymer nanoparticle was prepared. The nanoparticles were composed of a phenylboronic acid modified hydroxycamptothecin crosslinker (HCPT-diHMPBA) and a 1,2-diol-rich poly(ethylene oxide)- b -poly(glycerol monomethacrylate) diblock copolymer (PEG-PGMA), and crosslinked...
Saved in:
Published in: | Polymer chemistry 2015-01, Vol.6 (1), p.173-1713 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A new kind of drug-crosslinked polymer nanoparticle was prepared. The nanoparticles were composed of a phenylboronic acid modified hydroxycamptothecin crosslinker (HCPT-diHMPBA) and a 1,2-diol-rich poly(ethylene oxide)-
b
-poly(glycerol monomethacrylate) diblock copolymer (PEG-PGMA), and crosslinked by a phenylboronic ester bond. Dynamic light scattering measurement and electron microscopy observation revealed that the nanoparticles had a spherical morphology with a hydrodynamic diameter of 146 nm. The phenylboronic acid modified hydroxycamptothecin crosslinker could be released from the nanoparticles in a sustained manner and converted into pharmaceutically active hydroxycamptothecin (HCPT) in an enzyme-containing medium, as shown in the
in vitro
cytotoxicity test. Cellular uptake examination by confocal laser scanning microscopy showed that the nanoparticles were well internalized by cancer cells and active HCPT was found inside the cells.
A new kind of drug-crosslinked polymer nanoparticle was synthesized. The nanoparticles were composed by a phenylboronic acid modified 10-hydroxycamptothecin (the crosslinker) and 1,2-diol-rich PEG-PGMA diblock copolymer (the backbone), and crosslinked by phenylboronic ester bond. |
---|---|
ISSN: | 1759-9954 1759-9962 |
DOI: | 10.1039/c4py01722f |